Title |
Fundamental deficiencies in the megatrial methodology
|
---|---|
Published in |
Trials, January 2001
|
DOI | 10.1186/cvm-2-1-002 |
Pubmed ID | |
Authors |
Bruce G Charlton |
Abstract |
The fundamental methodological deficiency of megatrials is deliberate reduction of experimental control in order to maximize recruitment and compliance of subjects. Hence, typical megatrials recruit pathologically and prognostically heterogeneous subjects, and protocols typically fail to exclude significant confounders. Therefore, most megatrials do not test a scientific hypothesis, nor are they informative about individual patients. The proper function of a megatrial is precise measurement of effect size for a therapeutic intervention. Valid megatrials can be designed only when simplification can be achieved without significantly affecting experimental control. Megatrials should be conducted only at the end of a long process of therapeutic development, and must always be designed and interpreted in the context of relevant scientific and clinical information. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Australia | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 31% |
Other | 3 | 19% |
Student > Postgraduate | 2 | 13% |
Student > Master | 2 | 13% |
Student > Ph. D. Student | 1 | 6% |
Other | 2 | 13% |
Unknown | 1 | 6% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 75% |
Psychology | 2 | 13% |
Social Sciences | 1 | 6% |
Unknown | 1 | 6% |